Thursday, January 3, 2013
Questcor Pharmaceuticals Buys BioVectra
QuestCor Pharmaceuticals, the Anaheim-based biopharmaceuticals firm providing treatments for autoimmune and inflammatory disorders, said yetserday that it has acquired BioVectra, a supplier of contract manufacturing services to the pharmaceuticals and biotechnology industry. The deal was worth approximately $50.7M (C$50M). BioVectra has been Questcor's manufacturing partner for nearly a decade, and is based in Prince Edward Island, Canada.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More